Dr Simon Boulton

Simon Boulton is a senior group leader at the Francis Crick Institute, London. For 25 years, Simon’s work has focused on the discovery of DNA repair genes and providing molecular insights into genome instability disorders and cancer. Simon is also co-founder and VP Science Strategy of Artios Pharma Ltd, a biotech company that is developing DNA repair inhibitors to selectively kill cancer cells either as mono-therapies or in combination with existing treatments. Simon is an EMBO Member, Fellow of the Academic of Medical Sciences and has been awarded the Royal Society Francis Crick Medal, the EMBO Gold Medal and the Paul Marks Prize for Cancer Research.